Manufacturer record
Medicross Laboratories Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Medicross Laboratories Pvt. Ltd (Himachal Pradesh) was declared Not of Standard Quality in September 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MNT27015, Tramadol Hydrochloride Sustained Release Tablets I.P. 100mg - (exp Dec 2026). Directorate of Food & Drugs, Bambolim, Goa (state lab) found it not of standard quality: Spurious identification, Dissolution and Assay. Listed in the September 2025 alert.
Records by type
1 record linked to Medicross Laboratories Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Tramadol Hydrochloride Sustained Release Tablets I.P. 100mg - | Batch MNT27015Mfg Jan 2025 · Exp Dec 2026 | Spurious identification, Dissolution and Assay.Assay | Directorate of Food & Drugs, Bambolim, GoaState lab | Sep 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.